GENE ONLINE|News &
Opinion
Blog

Chugai Pharmaceutical
Japan’s Red Biotechnology and International Business Partnering Take Spotlight on BioJapan 2023
2023-11-03
Building Bridges at the Brand-New Chugai Life Science Park
2023-10-10
Japan’s Chugai Infuses $500 Million for a New API Manufacturing Building
2021-07-29
Chugai Initiates Actemra’s Phase 3 COVID-19 Trials in Japan
2020-04-11
FDA
Weekly Cover:Foundation Medicine and Chugai Partnership with National Cancer Center
2020-02-18
Weekly Cover: Expansion of Samsung Biologics Projects into U.S. and Europe
2020-02-11
Weekly Cover: Acepodia’s NK Cell Therapy Drug Candidate ACE1702 Receives FDA Clearance of IND
2020-01-15
Weekly in Asia|Nov-3
2019-12-03
Weekly in Asia|Nov
2019-11-07
Weekly in Asia(0407-0413)
2019-04-19
Roche Announces Analysis of Hemlibra’s Phase III HAVEN 2 Study at ASH meeting
2018-12-21
Emicizumab promises weekly/biweekly prophylaxis in hemophilia-A patients
2018-09-04
LATEST
Eli Lilly Breaks Records with $9B Total Investment in Indiana Weight-loss Drug Expansion
2024-05-27
New Regulatory Measures in China A First in the Fight Against Sedentary Behavior in Children
2024-05-24
Cure Genetics Announced Promising Safety and Efficacy Data of CAR-NKT Product CGC729 for RCC at ASGCT 2024
2024-05-23
AstraZeneca’s $1.5 Billion ADC Manufacturing Facility in Singapore
2024-05-23
Hims & Hers Health Inc. Tipping the Scales of the Weight Loss Market — and Wall Street is Loving it!
2024-05-22
GV Announces Cooperation with CICC
2024-05-22
Eli Lilly and Aktis Oncology Partner to Advance Novel Radiopharmaceuticals
2024-05-22
EVENT
Scroll to Top